CATALOGO DEI PRODOTTI DELLA RICERCA

LANZAFAME, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.228
EU - Europa 2.940
AS - Asia 2.073
SA - Sud America 302
AF - Africa 69
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.142
RU - Federazione Russa 1.150
SG - Singapore 867
CN - Cina 593
GB - Regno Unito 529
IT - Italia 256
BR - Brasile 250
SE - Svezia 195
VN - Vietnam 184
DE - Germania 176
IE - Irlanda 161
HK - Hong Kong 150
FR - Francia 149
FI - Finlandia 131
KR - Corea 66
CA - Canada 48
UA - Ucraina 43
BD - Bangladesh 36
IN - India 34
JP - Giappone 34
ZA - Sudafrica 26
AR - Argentina 25
MX - Messico 24
PL - Polonia 24
NL - Olanda 22
CZ - Repubblica Ceca 21
TR - Turchia 20
ID - Indonesia 18
IQ - Iraq 15
NG - Nigeria 15
BE - Belgio 14
ES - Italia 12
AT - Austria 10
CO - Colombia 10
BF - Burkina Faso 8
UZ - Uzbekistan 8
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 7
CL - Cile 6
PH - Filippine 6
RO - Romania 6
AU - Australia 5
CH - Svizzera 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GR - Grecia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EC - Ecuador 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BJ - Benin 1
CD - Congo 1
DZ - Algeria 1
GY - Guiana 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
ZW - Zimbabwe 1
Totale 8.622
Salva come PNG Salva come JPEG
Città #
Singapore 490
Southend 416
Moscow 409
Chandler 389
Ashburn 297
San Jose 293
Jacksonville 245
Woodbridge 234
Dallas 195
Dublin 160
Hong Kong 148
Ann Arbor 140
Beijing 120
Verona 94
Council Bluffs 79
New York 79
Los Angeles 75
The Dalles 72
Ho Chi Minh City 58
Lawrence 53
Princeton 53
Helsinki 48
Houston 46
Jinan 45
Munich 45
Nanjing 44
Shenyang 43
Wilmington 43
Hanoi 37
Santa Clara 32
Tokyo 31
São Paulo 29
Buffalo 25
Warsaw 24
Hebei 21
Denver 20
London 20
Montreal 20
Orem 20
Turku 20
Atlanta 19
Frankfurt am Main 19
Tianjin 19
Brno 18
Bologna 17
Boardman 16
Redondo Beach 16
Seoul 16
Toronto 16
Ningbo 15
Zhengzhou 15
Abuja 14
Brussels 14
Haikou 14
Johannesburg 14
Bloomsbury 13
Phoenix 13
Sindelfingen 13
Changsha 12
Milan 12
Amsterdam 11
Chennai 11
Guangzhou 11
Hangzhou 11
Nanchang 11
San Francisco 11
Seattle 11
Taizhou 11
Boston 10
Columbus 10
Jiaxing 10
Redmond 10
Stockholm 10
Jakarta 9
Norwalk 9
Redwood City 9
Rio de Janeiro 9
Brooklyn 8
Chicago 8
Da Nang 8
Dong Ket 8
Fuzhou 8
Haiphong 8
Ouagadougou 8
Baghdad 7
Clearwater 7
Lanzhou 7
Manchester 7
Nuremberg 7
Poplar 7
Tashkent 7
Belo Horizonte 6
City of London 6
Falls Church 6
Mexico City 6
Mumbai 6
Taiyuan 6
Washington 6
Curitiba 5
Madrid 5
Totale 5.348
Salva come PNG Salva come JPEG
Nome #
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic 244
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 241
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. 216
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 214
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 211
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 207
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 199
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 192
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 187
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 186
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 185
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 183
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 182
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 179
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 177
Primary cutaneous cryptococcosis in a HIV infested patient: case report. 176
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 176
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 173
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 172
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 172
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 169
No improvement of lipodystrophy syndrome in an HIV-infected patient. 165
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 165
Can we really identify HIV-1 long-term nonprogressors? 164
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 163
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 161
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 161
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 161
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 160
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 157
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 156
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 149
Antiretroviral therapy in low-resource settings 147
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection 146
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 145
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 144
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 141
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 136
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 135
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 133
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 130
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 129
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose 128
The treatment of latent TB infection in HIV-positive people: the Verona experience 128
Inflammatory pseudotumor of lymph nodes. 127
Raltegravir: is a 400 mg once-daily dose enough? 123
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 122
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 121
The major genetic determinants of HIV-1 control affect HLA Class I Peptide presentation 120
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital 116
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 106
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 104
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 85
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. 85
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 75
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs-Experience From Northern Italy 32
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 27
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 26
Totale 8.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.650
article - articoli 28.450
book - libri 0
conference - conferenze 200
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022489 44 151 4 66 6 8 5 22 26 15 32 110
2022/20231.035 58 137 83 164 100 256 3 71 122 6 20 15
2023/2024486 26 45 52 39 63 84 6 26 6 28 63 48
2024/20251.148 59 81 37 175 59 27 66 39 184 71 105 245
2025/20263.762 256 200 188 637 1.038 258 312 165 341 230 60 77
Totale 8.714